Tang Kevin
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1178579. Latest Form 4 filed Oct 26, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Boundless Bio, Inc.BOLD | 10% owner | 3 | 2026-10-22 | 2026-10-26 |
Transactions: 3
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-26 | Boundless Bio, Inc.10% owner | Purchase | 9,606 | $2.38 | $22.9k | Form 4 |
| 2026-10-23 | Boundless Bio, Inc.10% owner | Purchase | 6,234 | $2.38 | $14.8k | Form 4 |
| 2026-10-22 | Boundless Bio, Inc.10% owner | Purchase | 5,800 | $2.40 | $13.9k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 15:18 ET. Listed shows no prices and gives no investment advice.